IgE-mediated anaphylactic reaction to purified and recombinant factor VIII in a patient with severe haemophilia A

被引：16

作者：

Kadar, J. G.

Schuster, J.

Hunzelmann, N.

机构：

[1] Klin & Poliklin Dermatol & Vererol, D-50931 Cologne, Germany

[2] Univ Cologne, Outpatient Clin, Cologne, Germany

[3] Univ Cologne, Lab Transfus Med, Cologne, Germany

[4] Univ Cologne, Dept Dermatol, Cologne, Germany

来源：

HAEMOPHILIA | 2007年 / 13卷 / 01期

关键词：

allergy; bleeding disorder; IgE-mediated reaction; inhibitors; recombinant;

D O I：

10.1111/j.1365-2516.2006.01339.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We report a 51-year-old patient with severe haemophilia A developing a severe life-threatening anaphylactic reaction to recombinant factor VIII (rFVIII). Anaphylactic reactions are a rare but well-known side effect of FVIII products. The nature of these reactions could not be clarified as previous studies failed to demonstrate a specific IgE response. Here, we could prove a grade 3 anaphlyactic reaction as an IgE-mediated response to rFVIII for the first time by Western blotting.

引用

页码：104 / 105

页数：2

共 12 条

[1] Treating haemophilia A with recombinant blood factors: a comparison
Ananyeva, N
Khrenov, A
Darr, F
Summers, R
Sarafanov, A
Saenko, E
[J]. EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (05) : 1061 - 1070
[2] Behrmann M, 2002, THROMB HAEMOSTASIS, V88, P221
[3] Inhibitors: resolving diagnostic and therapeutic dilemmas
Dimichele, D
[J]. HAEMOPHILIA, 2002, 8 (03) : 280 - 287
[4] IgE-mediated allergy and desensitization to factor IX in hemophilia B
Dioun, AF
Ewenstein, BM
Geha, RS
Schneider, LC
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1998, 102 (01) : 113 - 117
[5] Recombinant factor VIIa - An update on its clinical use
Franchini, M
Zaffanello, M
Veneri, D
[J]. THROMBOSIS AND HAEMOSTASIS, 2005, 93 (06) : 1027 - 1035
[6] Influence of von Willebrand factor on the reactivity of human factor VIII inhibitors with factor VIII
Gensana, M
Altisent, C
Aznar, JA
Casaña, P
Hernández, F
Jorquera, JI
Magallón, M
Massot, M
Puig, L
[J]. HAEMOPHILIA, 2001, 7 (04) : 369 - 374
[7] Green D, 1999, HAEMOPHILIA, V5, P11
[8] GRINGERI A, 1991, THROMB HAEMOSTASIS, V65, P245
[9] Effective and safe use of recombinant factor VIIa (NovoSeven®) in elderly mild haemophilia A patients with high-titre antibodies against factor VIII
Leebeek, FWG
Kappers-Klunne, MC
Jie, KSG
[J]. HAEMOPHILIA, 2004, 10 (03) : 250 - 253
[10] Inhibitor development in correlation to factor VIII genotypes
Oldenburg, J
El-Maarri, O
Schwaab, R
[J]. HAEMOPHILIA, 2002, 8 : 23 - 29

← 1 2 →